STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride

Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 billion.

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

STAT+: The PBMs fight back, and arbitration doesn’t lose

We unpack the contentious fight over drug price transparency.

about 3 hours agoRead more →

MedPage Today

Make the Diagnosis: Is This Eruption Related to the Patient's Acne? His Ulcerative Colitis?

(MedPage Today) --

about 4 hours agoRead more →

MedPage Today

Trump Signs Order to Speed Review of Controversial Ibogaine, Other Psychedelics

(MedPage Today) -- President Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious...

about 4 hours agoRead more →

HealthDaily Composite

Stat News

STAT+: Finally cracking KRAS as a druggable target

The Breakthrough Prize winners, Trump's psychedelics executive order, and more biotech news from The Readout

about 5 hours agoRead more →

Related Health Stories

STAT+: The PBMs fight back, and arbitration doesn’t lose

Make the Diagnosis: Is This Eruption Related to the Patient's Acne? His Ulcerative Colitis?

Trump Signs Order to Speed Review of Controversial Ibogaine, Other Psychedelics

STAT+: Finally cracking KRAS as a druggable target